Skip to main content
Year archive

CJ Bioscience — 2022 filings

All 22 regulatory filings released by CJ Bioscience (311690) in 2022, sourced directly from the official regulator.

22 Filings
2022 Period
2022 filings (22)
Filing Released Lang
투자판단관련주요경영사항(마이크로바이옴 면역항암치료제 CJRB-101의 미국 FDA 제1/2상 임상시험계획(IND) 신청)
Regulatory Filings
2022-12-26 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2022-12-08 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount
2022-12-08 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Regulatory Filings
2022-11-29 Korean
분기보고서 (2022.09)
Interim / Quarterly Report 9M 2022
2022-11-14 Korean
투자판단관련주요경영사항(마이크로바이옴 공동연구 계약 체결)
Regulatory Filings
2022-09-01 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Regulatory Filings
2022-08-30 Korean
반기보고서 (2022.06)
Interim / Quarterly Report H1 2022
2022-08-16 Korean
[기재정정]사업보고서 (2020.12)
Annual Report FY 2020
2022-06-21 Korean
[기재정정]분기보고서 (2021.09)
Interim / Quarterly Report 9M 2021
2022-06-21 Korean
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Major Shareholding Notification
2022-05-31 Korean
[기재정정]대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Major Shareholding Notification
2022-05-31 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Q1 2022
2022-05-16 Korean
[기재정정]분기보고서 (2022.03)
Interim / Quarterly Report Q1 2022
2022-05-16 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2022-03-29 Korean
감사보고서제출
Audit Report / Information FY 2021
2022-03-21 Korean
사업보고서 (2021.12)
Audit Report / Information FY 2021
2022-03-21 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2022-03-14 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Major Shareholding Notification
2022-02-24 Korean
주주총회소집결의
AGM Information
2022-02-11 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2021
2022-01-10 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification
2022-01-07 Korean